NCT07699861Recruiting
LUCINAE Registry: Thoracic Cancers During Pregnancy
LUCINAE: LUng and Thoracic Cancers In pregNAncy rEgistry
Source: ClinicalTrials.gov · Last updated 21 Oct 2026
Brief summary (registry, in English)
The LUCINAE Registry is an international, multicenter observational study collecting data on patients with thoracic cancers (including lung cancer) who are expecting a child. This includes women diagnosed during pregnancy, women who become pregnant during or after cancer, and men receiving cancer treatment at the time their partner conceives. Because thoracic cancers during pregnancy are rare, there is limited information to guide clinical decisions. This registry aims to describe patient characteristics, diagnostic approaches, treatments, and maternal and fetal outcomes. Data are collected retrospectively and prospectively from participating centers. The results of this registry are expected to improve understanding of thoracic cancers in this setting and support the development of future clinical recommendations.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 11 May 2026
- Start date
- 23 Apr 2026
- Primary completion date
- Dec 2035
- Lead sponsor
- Oncology Institute of Southern Switzerland
- Diseases
- Lung cancer
- NCT number
- NCT07699861
What you commit to
- Study type: Observational
- Planned participants: 100
- From 23 Apr 2026 to the primary completion date, Dec 2035
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- 1\. Patient missing data about thoracic cancer stage and diagnosis
Other
- 2\. For retrospective patients, documented refusal to the use of clinical data for research purposes
Who the study is looking for
- 1\. All patients with a diagnosis of thoracic cancer (including lung cancer, mesothelioma, thymic epithelial tumors, neuroendocrine tumors or sarcoma of the thorax and other rare thoracic entities) and pregnancy (positive pregnancy test) including:
- Patients receiving a diagnosis of thoracic cancer during pregnancy
- Patients who became pregnant while having active thoracic cancer
- Patients previously treated for a thoracic cancer and becoming pregnant in the 5 years following end of treatment OR Men with a diagnosis of thoracic cancer (including lung cancer, mesothelioma, thymic epithelial tumors, neuroendocrine tumors or sarcoma of the thorax and other rare thoracic entities), who were undergoing active oncological treatment at the time their partner conceived their child.
- 2\. Available information about pregnancy outcomes
- 3\. Age ≥ 18 years
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kantonsspital Baden Coordinator of this site? Confirm its status | Baden | Switzerland | Recruiting |
| Istituto Oncologico della Svizzera Italiana (IOSI) Coordinator of this site? Confirm its status | Bellinzona | Switzerland | Recruiting |
| Geneva University Hospital (HUG) Coordinator of this site? Confirm its status | Geneva | Switzerland | Recruiting |
| Kantonsspital Winterthur Coordinator of this site? Confirm its status | Winterthur | Switzerland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.